TLR2-IN-C29
CAS: 363600-92-4
Ref. 3D-NPA60092
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
TLR2-IN-C29 is a novel compound that activates the AMPK pathway. This compound has been shown to have anti-cancer effects on HL60 cells and cervical cancer cells. The mechanism of action for TLR2-IN-C29 is not yet clear, but it may be due to its ability to activate methyl eicosanoate production, which inhibits the production of proinflammatory cytokines in macrophages and dendritic cells. TLR2-IN-C29 also has the potential to be used as a biomarker for autoimmune diseases such as liver cirrhosis and rheumatoid arthritis.
Chemical properties
Technical inquiry about: 3D-NPA60092 TLR2-IN-C29
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
